dc.contributor.author | Hasgul, Zeynep | |
dc.contributor.author | Spanjaart, Anne | |
dc.contributor.author | Javed, Sumreen | |
dc.contributor.author | Akhavan, Ali | |
dc.contributor.author | Kersten, Marie J. | |
dc.contributor.author | Jalali, Mohammad S. | |
dc.date.accessioned | 2024-11-08T16:36:39Z | |
dc.date.available | 2024-11-08T16:36:39Z | |
dc.date.issued | 2024-10-30 | |
dc.identifier.uri | https://hdl.handle.net/1721.1/157516 | |
dc.description.abstract | Understanding how treatments affect patients’ quality of life over time is crucial, but capturing the complex interactions of health factors poses a challenge for clinical and observational research. To overcome this, we have turned to simulation modeling, a method that allows for a more thorough exploration of these dynamics. Our study focuses on cancer immunotherapy, a treatment that, despite its potential to prolong survival, also comes with life-threatening risks. We evaluated the effectiveness of two strategies aimed at improving quality of life: reducing the time to treatment infusion and enhancing social support. These strategies were assessed across three different patient scenarios: those not initially eligible for treatment, patients experiencing a relapse, and patients showing a complete response. By using simulation modeling, we demonstrated how this approach can help explore the dynamics and interactions of various health factors and the impact of specific strategies. | en_US |
dc.publisher | Springer International Publishing | en_US |
dc.relation.isversionof | https://doi.org/10.1007/s11136-024-03810-0 | en_US |
dc.rights | Creative Commons Attribution | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_US |
dc.source | Springer International Publishing | en_US |
dc.title | Health-related quality of life dynamics: modeling insights from immunotherapy | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Hasgul, Z., Spanjaart, A., Javed, S. et al. Health-related quality of life dynamics: modeling insights from immunotherapy. Qual Life Res (2024). | en_US |
dc.contributor.department | Sloan School of Management | en_US |
dc.relation.journal | Quality of Life Research | en_US |
dc.identifier.mitlicense | PUBLISHER_CC | |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dc.date.updated | 2024-11-03T04:17:53Z | |
dc.language.rfc3066 | en | |
dc.rights.holder | The Author(s) | |
dspace.embargo.terms | N | |
dspace.date.submission | 2024-11-03T04:17:53Z | |
mit.license | PUBLISHER_CC | |
mit.metadata.status | Authority Work and Publication Information Needed | en_US |